Lupus (SLE): open trials in Georgia

• NCT06613360

  A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

  Trial Treatment · Phase 1 · Cullinan Therapeutics Inc.

  ARENSIA Exploratory Medicine LLC, Tbilisi

  Registry updated 2026-10-26

All Lupus (SLE) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error